Cargando…

Combined LRRK2 mutation, aging and chronic low dose oral rotenone as a model of Parkinson’s disease

Aging, genetics and environmental toxicity are important etiological factors in Parkinson’s disease (PD). However, its pathogenesis remains unclear. A major obstacle is the lack of an appropriate experimental model which incorporates genetic susceptibility, aging and prolonged environmental toxicity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Hui-Fang, Ho, Philip Wing-Lok, Leung, Gideon Chi-Ting, Lam, Colin Siu-Chi, Pang, Shirley Yin-Yu, Li, Lingfei, Kung, Michelle Hiu-Wai, Ramsden, David Boyer, Ho, Shu-Leong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241661/ https://www.ncbi.nlm.nih.gov/pubmed/28098219 http://dx.doi.org/10.1038/srep40887

Ejemplares similares

Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA)
por: Ho, Philip Wing-Lok, et al.
Publicado: (2019)

In vivo overexpression of synaptogyrin‐3 promotes striatal synaptic dopamine uptake in LRRK2(R1441G) mutant mouse model of Parkinson's disease
por: Ho, Philip Wing‐Lok, et al.
Publicado: (2023)

LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease
por: Pang, Shirley Yin-Yu, et al.
Publicado: (2022)

Aberrant mitochondrial morphology and function associated with impaired mitophagy and DNM1L-MAPK/ERK signaling are found in aged mutant Parkinsonian LRRK2(R1441G) mice
por: Liu, Huifang, et al.
Publicado: (2020)

LRRK2 mutant knock-in mouse models: therapeutic relevance in Parkinson's disease
por: Chang, Eunice Eun Seo, et al.
Publicado: (2022)

LRRK2 R1441G mice are more liable to dopamine depletion and locomotor inactivity
por: Liu, Hui-Fang, et al.
Publicado: (2014)

The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson’s disease
por: Pang, Shirley Yin-Yu, et al.
Publicado: (2019)

Long-term inhibition of mutant LRRK2 hyper-kinase activity reduced mouse brain α-synuclein oligomers without adverse effects
por: Ho, Philip Wing-Lok, et al.
Publicado: (2022)

Transcriptional Regulation of the Synaptic Vesicle Protein Synaptogyrin-3 (SYNGR3) Gene: The Effects of NURR1 on Its Expression
por: Li, Lingfei, et al.
Publicado: (2022)

Assessment of Cellular Estrogenic Activity Based on Estrogen Receptor-Mediated Reduction of Soluble-Form Catechol-O-Methyltransferase (COMT) Expression in an ELISA-Based System
por: Ho, Philip Wing-Lok, et al.
Publicado: (2013)

Uncoupling Protein-4 (UCP4) Increases ATP Supply by Interacting with Mitochondrial Complex II in Neuroblastoma Cells
por: Ho, Philip Wing-Lok, et al.
Publicado: (2012)

PMCA4 (ATP2B4) Mutation in Familial Spastic Paraplegia
por: Li, Miaoxin, et al.
Publicado: (2014)

PMCA4 (ATP2B4) mutation in familial spastic paraplegia causes delay in intracellular calcium extrusion
por: Ho, Philip Wing-Lok, et al.
Publicado: (2015)

Rotenone, Paraquat, and Parkinson’s Disease
por: Tanner, Caroline M., et al.
Publicado: (2011)

Antioxidants inhibit neuronal toxicity in Parkinson's disease‐linked LRRK2
por: Angeles, Dario C., et al.
Publicado: (2016)

Mitochondrial Uncoupling Protein-2 (UCP2) Mediates Leptin Protection Against MPP(+) Toxicity in Neuronal Cells
por: Ho, Philip Wing-Lok, et al.
Publicado: (2009)

LRRK2 Knockout Confers Resistance in HEK-293 Cells to Rotenone-Induced Oxidative Stress, Mitochondrial Damage, and Apoptosis
por: Quintero-Espinosa, Diana Alejandra, et al.
Publicado: (2023)

Rotenone Blocks the Glucocerebrosidase Enzyme and Induces the Accumulation of Lysosomes and Autophagolysosomes Independently of LRRK2 Kinase in HEK-293 Cells
por: Perez-Abshana, Laura Patricia, et al.
Publicado: (2023)

The role of autophagy in Parkinson's disease: rotenone-based modeling
por: Xiong, Nian, et al.
Publicado: (2013)

Piracetam and vinpocetine ameliorate rotenone-induced Parkinsonism in rats
por: Zaitone, Sawsan A., et al.
Publicado: (2012)

Models for LRRK2-Linked Parkinsonism
por: Li, Tianxia, et al.
Publicado: (2011)

The role of the LRRK2 gene in Parkinsonism
por: Li, Jie-Qiong, et al.
Publicado: (2014)

LRRK2 and Proteostasis in Parkinson’s Disease
por: Pérez-Carrión, María Dolores, et al.
Publicado: (2022)

Targeting LRRK2 in Parkinson’s disease
por: Xiao, Bin, et al.
Publicado: (2022)

LRRK2 A419V Is Not Associated with Parkinson's Disease in Different Chinese Populations
por: Wu, Yih Ru, et al.
Publicado: (2012)

Phos-tag analysis of Rab10 phosphorylation by LRRK2: a powerful assay for assessing kinase function and inhibitors
por: Ito, Genta, et al.
Publicado: (2016)

Neuroprotective potential of ferulic acid in the rotenone model of Parkinson’s disease
por: Ojha, Shreesh, et al.
Publicado: (2015)

Inhibitors of Leucine Rich Repeat Kinase 2 (LRRK2) Protect Against LRRK2-Models of Parkinson’s Disease
por: Lee, Byoung Dae, et al.
Publicado: (2010)

Baicalein antagonizes rotenone-induced apoptosis in dopaminergic SH-SY5Y cells related to Parkinsonism
por: Song, Ju-Xian, et al.
Publicado: (2012)

Rare variants in LRRK1 and Parkinson's disease
por: Schulte, Eva C., et al.
Publicado: (2013)

The Role of LRRK2 in Neurodegeneration of Parkinson Disease
por: Rui, Qin, et al.
Publicado: (2018)

LRRK2 and the Endolysosomal System in Parkinson’s Disease
por: Erb, Madalynn L., et al.
Publicado: (2020)

LRRK2 at the Crossroad of Aging and Parkinson’s Disease
por: Hur, Eun-Mi, et al.
Publicado: (2021)

Pathological Functions of LRRK2 in Parkinson’s Disease
por: Jeong, Ga Ram, et al.
Publicado: (2020)

Modeling Parkinson’s disease in LRRK2 rodents
por: Domenicale, Chiara, et al.
Publicado: (2023)

Neuroprotective effects of aldehyde dehydrogenase 2 activation in rotenone-induced cellular and animal models of parkinsonism
por: Chiu, Ching-Chi, et al.
Publicado: (2014)

Development of phospho-specific Rab protein antibodies to monitor in vivo activity of the LRRK2 Parkinson's disease kinase
por: Lis, Pawel, et al.
Publicado: (2018)

Edaravone Guards Dopamine Neurons in a Rotenone Model for Parkinson's Disease
por: Xiong, Nian, et al.
Publicado: (2011)

Stereotaxical Infusion of Rotenone: A Reliable Rodent Model for Parkinson's Disease
por: Xiong, Nian, et al.
Publicado: (2009)

Progression of Parkinson's Disease Pathology Is Reproduced by Intragastric Administration of Rotenone in Mice
por: Pan-Montojo, Francisco, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_qf8h0k2r6j8gecsa6o30j0km6a